This dysregulation is evident in AD, where miR-29 and miR-125b reduction possibly correlates with tau pathology, but it is equally relevant in ALS and Huntington’s, where cytoskeletal collapse drives early synaptic failure [107]. This evidence concerns the gene MAPT and Alzheimer disease.